Last reviewed · How we verify
bortezomib, dexamethasone, thalidomide, and cyclophosphamide
bortezomib, dexamethasone, thalidomide, and cyclophosphamide is a Small molecule drug developed by Millennium Pharmaceuticals, Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | bortezomib, dexamethasone, thalidomide, and cyclophosphamide |
|---|---|
| Sponsor | Millennium Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy (PHASE3)
- Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. (PHASE2)
- 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy (PHASE2)
- Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara (PHASE2)
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (PHASE2)
- UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (PHASE2)
- UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma (PHASE3)
- Velcade (Bortezomib) Consolidation After Transplant (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bortezomib, dexamethasone, thalidomide, and cyclophosphamide CI brief — competitive landscape report
- bortezomib, dexamethasone, thalidomide, and cyclophosphamide updates RSS · CI watch RSS
- Millennium Pharmaceuticals, Inc. portfolio CI
Frequently asked questions about bortezomib, dexamethasone, thalidomide, and cyclophosphamide
What is bortezomib, dexamethasone, thalidomide, and cyclophosphamide?
bortezomib, dexamethasone, thalidomide, and cyclophosphamide is a Small molecule drug developed by Millennium Pharmaceuticals, Inc..
Who makes bortezomib, dexamethasone, thalidomide, and cyclophosphamide?
bortezomib, dexamethasone, thalidomide, and cyclophosphamide is developed by Millennium Pharmaceuticals, Inc. (see full Millennium Pharmaceuticals, Inc. pipeline at /company/millennium-pharmaceuticals-inc).
What development phase is bortezomib, dexamethasone, thalidomide, and cyclophosphamide in?
bortezomib, dexamethasone, thalidomide, and cyclophosphamide is in Phase 2.